Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003059
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Comply with the diagnostic criteria for general type COVID-19 in the Diagnosis and Treatment Program for COVID-19(trial version 6th).
(2) Aged >= 18 years.
(3) Agree to participate in the trial, and the patient, the legal guardian or the person in charge of the medical institution signed the informed consent through paper signature, electronic signature of mobile phone software, or voice authorization.
(1) Critical patients.
(2) Patients who can not guarantee compliance of using TCM during the treatment period, or patients who are difficult to take medicine by oral or nasal route.
(3) Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19.
(4) Pregnant or parturient women. Patient who have a pregnancy plan or a positive urine pregnancy test.
(5) Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the trial.
(6) Patients who have been allergic or intolerant to taking TCM.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time to 2019-nCoV RNA negativity in patients;
- Secondary Outcome Measures
Name Time Method Blood routine test outcomes;The rate of critcal aggravation;Blood biochemical test outcomes;The 7-point scale;